Anoctamin 2 identified as an autoimmune target in multiple sclerosis
Open accessThe DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
Significance: Despite the growing evidence that autoantibodies are team players in the pathogenesis of multiple sclerosis (MS), the target autoantigens are yet to be identified. In this work, we mined the autoantibody repertoire within MS by screening more than 2,000 plasma samples from patients with MS and controls and identified increased autoantibody reactivity against an ion-channel protein called “anoctamin 2” (ANO2). This finding points toward an ANO2 autoimmune sub-phenotype in MS and might contribute to the development of clinical algorithms to characterize a subgroup of MS patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Interestingly, ANO2 has been identified as an autoimmune target in multiple sclerosis, where decreased macular volume and peripapillary retinal nerve fiber layer thinning are observed.37–39”
From ANO2 Genetic Variants and Anti-VEGF Treatment Response in Neovascular AMD: A Pharmacogenetic Substudy of VIEW 1 and VIEW 2 (2024) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Tissue-based map of the human proteome
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286 · cited 1×
“The Human Protein Atlas is an initiative systematically producing human protein fragments, where regions from protein-encoding genes are selected based on low similarity to other proteins in the proteome (4).”
BackgroundSelf-citationGenetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697 · cited 1×
“Genotyping was carried out in previous studies analyzing the genetic risk of MS for the individuals included in this study (35, 36).”
MethodLock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A., Strober, S., Cannella, B., Allard, J., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-500 · Cited by 1,669
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
International Multiple Sclerosis Genetics Consortium (IMSGC) (2013) · Nature Genetics · doi:10.1038/ng.2770 · Cited by 1,386 · cited 1×
“Genotyping was carried out in previous studies analyzing the genetic risk of MS for the individuals included in this study (35, 36).”
TMEM16A confers receptor-activated calcium-dependent chloride conductance
Yang, Y. D., Cho, H., Koo, J. Y., Tak, M. H., Cho, Y., Shim, W.-S., Park, S. P., Lee, J., Lee, B., Kim, B.-M., et al. (2008) · Nature · doi:10.1038/nature07313 · Cited by 1,283 · cited 1×
“ANO2, also known as TMEM16B, is one of 10 members of the recently discovered anoctamin family (22, 23).”
BackgroundTMEM16A, A Membrane Protein Associated with Calcium-Dependent Chloride Channel Activity
Caputo, A., Caci, E., Ferrera, L., Pedemonte, N., Barsanti, C., Sondo, E., Pfeffer, U., Ravazzolo, R., Zegarra-Moran, O., & Galietta, L. J. V. (2008) · Science · doi:10.1126/science.1163518 · Cited by 1,263 · cited 1×
“ANO2, also known as TMEM16B, is one of 10 members of the recently discovered anoctamin family (22, 23).”
BackgroundMultiple sclerosis: a complicated picture of autoimmunity
McFarland, H. F., & Martin, R. (2007) · Nature Immunology · doi:10.1038/ni1507 · Cited by 985 · cited 1×
“There are several indications that MS is an immune-mediated disease, most likely caused by autoimmune mechanisms (1).”
BackgroundKim, B. J., Nam, J. H., Kim, K. H., Joo, M., Ha, T. S., Weon, K. Y., Choi, S., Jun, J. Y., Park, E. J., Wie, J., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000366306 · Cited by 886
ROTHMAN, K. J., GREENLAND, S., & WALKER, A. M. (1980) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113015 · Cited by 859 · cited 1×
“For HLA interaction analysis, interactions between risk factors were examined by calculating the departure from additivity of effects, the AP due to interaction with 95% confidence intervals, and the corresponding P value (APp) (40, 41).”
Method
Research works printed but not linked: 1
- KJ Rothman, S Greenland, TL Lash Modern Epidemiology (Lippincott Williams & Wilkins, 3rd Ed, Philadelphia, 2008).
Cited by
Systems vaccinology of the BNT162b2 mRNA vaccine in humans
Arunachalam, P. S., Scott, M. K. D., Hagan, T., Li, C., Feng, Y., Wimmers, F., Grigoryan, L., Trisal, M., Edara, V. V., Lai, L., et al. (2021) · Nature · doi:10.1038/s41586-021-03791-x · Cited by 572
New-onset IgG autoantibodies in hospitalized patients with COVID-19
Chang, S. E., Feng, A., Meng, W., Apostolidis, S. A., Mack, E., Artandi, M., Barman, L., Bennett, K., Chakraborty, S., Chang, I., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25509-3 · Cited by 489
Tengvall, K., Huang, J., Hellström, C., Kammer, P., Biström, M., Ayoglu, B., Lima Bomfim, I., Stridh, P., Butt, J., Brenner, N., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1902623116 · Cited by 238
“The correlation between anti-ANO2 antibody levels between the previous (20) and the current study was high, which was reassuring considering the methodological differences.”
BackgroundResultInfluentialSelf-citationCross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosis
Thomas, O. G., Bronge, M., Tengvall, K., Akpinar, B., Nilsson, O. B., Holmgren, E., Hessa, T., Gafvelin, G., Khademi, M., Alfredsson, L. S., et al. (2023) · Science Advances · doi:10.1126/sciadv.adg3032 · Cited by 166
Self-citationClonal Evolution of Autoreactive Germinal Centers
Degn, S. E., van der Poel, C. E., Firl, D. J., Ayoglu, B., Al Qureshah, F. A., Bajic, G., Mesin, L., Reynaud, C.-A., Weill, J.-C., Utz, P. J., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.026 · Cited by 140
“The analysis was extended and refined by screening with autoAg arrays (Ayoglu et al., 2016), where each clone was assayed against 241 Ags (227 unique targets) and 30 controls (10 unique antibodies) (Table S3), and overall, results were congruent with the HEp-2 and nucleolar ELISA results (FiguresS3G–S3K).”
MethodResultInfluentialSelf-citation
Metadata
- Authors
- Ayoglu, B., Mitsios, N., Kockum, I., Khademi, M., Zandian, A., Sjöberg, R., Forsström, B., Bredenberg, J., Lima Bomfim, I., Holmgren, E., Grönlund, H., Guerreiro-Cacais, A. O., Abdelmagid, N., Uhlén, M., Waterboer, T., Alfredsson, L., Mulder, J., Schwenk, J. M., Olsson, T., & Nilsson, P.
- Affiliations
- Science for Life Laboratory (SE)
- Karolinska Institutet (SE)
- Neuroimmunology Unit, Department of Clinical Neuroscience, Karolinska Institute, SE-17177 Stockholm, Sweden;
- German Cancer Research Center (DE)
- Region Stockholm (SE)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2016-02-09
- Volume
- 113
- Issue
- 8
- Pages
- 2188-2193
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC4776531
- OpenAlex
- W2255924482
- Cited by
- 111
- References
- 42
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 13 · 2023: 16 · 2022: 10 · 2021: 13 · 2020: 7 · 2019: 14 · 2018: 5 · 2017: 12 · 2016: 8
- FWCI
- 11.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- multiple sclerosis, ANO2, autoantibodies, autoantigens, autoantibody repertoire, HLA-DRB1*15, epitope mapping, chloride channels, MS lesions, autoimmunity
- MeSH terms
- Anoctamins, Adolescent, Adult, Aged, Autoantibodies, Autoantigens, Brain, Female, Humans, Immunohistochemistry, Male, Membrane Proteins, Middle Aged, Multiple Sclerosis, Peptide Fragments, Case-Control Studies, Chloride Channels, Epitope Mapping, Young Adult, HLA-DRB1 Chains
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anoctamin 2 identified as an autoimmune target in multiple sclerosis. https://app.cochat.ai/papers/10.1073/pnas.1518553113
- The paper
- Ayoglu, B., Mitsios, N., Kockum, I., Khademi, M., Zandian, A., Sjöberg, R., Forsström, B., Bredenberg, J., Lima Bomfim, I., Holmgren, E., Grönlund, H., Guerreiro-Cacais, A. O., Abdelmagid, N., Uhlén, M., Waterboer, T., Alfredsson, L., Mulder, J., Schwenk, J. M., Olsson, T., & Nilsson, P. (2016). Anoctamin 2 identified as an autoimmune target in multiple sclerosis. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1518553113
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.